NFE2L2 and breast carcinoma: We found that the Hazard ratio was significantly different for lung metastasis but not for brain and bone metastasis (Figure 6H), indicating that NRF2 overexpression is advantageous for the survival of breast cancer cells in the lungs compared to brain or bone.